Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy

Abstract

OBJECTIVE:

To evaluate the effect and safety of treatment with low-calorie formula diet on renal function and proteinuria in obese patients with diabetic nephropathy.

DESIGN:

Prospective study on safety and efficacy of a 4-week low-calorie (11–19 kcal/kg/day) normal-protein (0.9–1.2 g/kg/day) diet partly supplemented with formula diet.

SUBJECTS:

In all, 22 obese patients with diabetic nephropathy (BMI: 30.4±5.3 kg/m2, HbA1c: 7.1±1.4%, serum creatinine: 172.4±57.5 μmol/l, urinary protein: 3.3±2.6 g/day).

RESULTS:

The mean body weight decreased by 6.2±3.0 kg. The mean systolic blood pressure, creatinine, blood urea nitrogen, urinary protein, and 8-hydroxydeoxyguanosine decreased significantly by 7.5±12.7 mmHg, 41.6±23.9 μmol/l, 1.50±1.61 mmol/l, 1.8±1.7 g/day, and 3.1±3.6 ng/mg creatinine, respectively. No patient had increased serum creatinine and urinary protein. Mean creatinine clearance (40.6±17.9 to 46.1±14.6 ml/s/1.73 m2) and serum albumin showed no significant changes. Δserum creatinine and Δurinary protein correlated with Δbody weight (r=0.62 and 0.49, respectively) and Δvisceral fat area (r=0.58 and 0.58, respectively), but did not correlate with Δsystolic blood pressure, Δfasting blood glucose and Δsubcutaneous fat area.

CONCLUSION:

These results suggested that weight reduction using formula diet might improve renal function and proteinuria safely for a short term in obese patients with diabetic nephropathy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. De Fronzo RA . Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 1995; 3: 510–564.

    Google Scholar 

  2. Mogensen CE . How to protect the kidney in diabetic patients with special reference to IDDM. Diabetes 1997; 46: S104–S110.

    Article  CAS  Google Scholar 

  3. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1990; 329: 977–986.

  4. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W . Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without nephropathy. Nephrol Dial Transplant 1998; 13: 2829–2832.

    Article  CAS  Google Scholar 

  5. Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovannetti S . Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 1988; 29: 280–287.

    CAS  PubMed  Google Scholar 

  6. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, Viberti GC . Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989; ii: 1411–1415.

    Article  Google Scholar 

  7. Zeller K, Wittaker E, Sullivan L, Raskin P, Jacobson HR . Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78–84.

    Article  CAS  Google Scholar 

  8. Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL . Effect of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995; 70: 35–41.

    Article  CAS  Google Scholar 

  9. Nakamura H, Ebe N, Ito S, Shibata A . Renal effects of different types of protein in healthy volunteer subjects and diabetic patients. Diabetes Care 1993; 16: 1071–1075.

    Article  CAS  Google Scholar 

  10. Mark K, Carlos J, Bruce N . Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989; 86: 9697–9701.

    Article  Google Scholar 

  11. Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS . Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984; 27: 547–556.

    Article  CAS  Google Scholar 

  12. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.

    Article  Google Scholar 

  13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.

  14. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M . Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103–117.

    Article  CAS  Google Scholar 

  15. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L . Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998; 24: 296–301.

    Article  CAS  Google Scholar 

  16. Allen TJ, Waldron MJ, Casley D, Jerums G, Cooper ME . Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes. Diabetes 1997; 46: 19–24.

    Article  CAS  Google Scholar 

  17. Jennette JC, Charles L, Grubb W . Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep-apnea syndrome. Am J Kidney Dis 1987; 10: 470–472.

    Article  CAS  Google Scholar 

  18. Kambham N, Markowitz G, Valeri AM, Lin J, D'Agati VD . Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498–1509.

    Article  CAS  Google Scholar 

  19. Morales E, Angeles M, Leon M, Hernandez E, Praga M . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 1980; 41: 319–327.

    Article  Google Scholar 

  20. Stokholm KH, Brochner-Mortensen J, Hoilund-Carlsen PF . Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 1980; 4: 57–63.

    CAS  PubMed  Google Scholar 

  21. Kasiske BL, Crosson JT . Renal disease in patients with massive obesity. Arch Intern Med 1986; 146: 1105–1109.

    Article  CAS  Google Scholar 

  22. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA . Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999; 56: 860–872.

    Article  CAS  Google Scholar 

  23. van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J, Lundkvist I, Bringman S, Arner P . The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 2000; 24: 673–678.

    Article  CAS  Google Scholar 

  24. Erdos B, Snipes JA, Miller AW, Busija DW . Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 2004; 53: 1352–1359.

    Article  Google Scholar 

  25. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H . Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 2004; 37: 115–123.

    Article  CAS  Google Scholar 

  26. Funatsu H, Yamashita H, Ohashi Y, Ishigaki T . Effect of rapid glycemic control on progression of diabetic retinopathy. Jpn J Ophthalmol 1992; 36: 356–367.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Miyashita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saiki, A., Nagayama, D., Ohhira, M. et al. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes 29, 1115–1120 (2005). https://doi.org/10.1038/sj.ijo.0803009

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803009

Keywords

This article is cited by

Search

Quick links